Paris-based biotechnology and AI company building a proprietary data-generation platform and AI virtual cell model to predict how human cells respond over time to drugs and genetic changes
Paris-based biotechnology and AI company building a proprietary data-generation platform and AI virtual cell model to predict how human cells respond over time to drugs and genetic changes. It generates multimodal, time-resolved single-cell data using a purpose-built automated wet lab, then trains models intended to simulate cellular responses in silico and support drug discovery.